Merck & Co Inc (MRK)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$119.85

Buy

$119.91

arrow-down$-0.96 (-0.79%)

Prices updated at 02 Apr 2026, 19:02 EDT

Prices minimum 15 mins delay

Prices in USD

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

S&P 500

-0.24%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	64,168m	65,011m
	48,975m	48,629m
	20,221m	22,107m
	31.51	34.01
	17,117m	18,254m
	25,706m	28,262m
Sales, General and administrative	10,816m	10,733m
Interest expenses	1,271m	1,357m
Provision for income taxes	2,803m	2,804m
Operating expenses	28,754m	26,522m
Income before taxes	19,936m	21,067m
Net income available to common shareholders	17,117m	18,254m
	6.76	7.3
Net interest income	-856m	-1,014m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	6.74	7.28
Free cash flow per share	5.8368	5.1797
Book value/share	17.6062	20.9527
Debt equity ratio	0.744111	0.888682

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	38,782m	43,516m
Current liabilities	28,420m	28,327m
Total capital	80,775m	99,356m
Total debt	37,111m	49,339m
Total equity	46,313m	52,606m
Total non current liabilities	-	-
Loans	34,462m	46,750m
Total assets	117,106m	136,866m
Total liabilities	-	-
Cash and cash equivalents	13,242m	14,565m
Common stock	2,528m	2,475m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	6,909m	13,318m
Cash dividends paid	-7,840m	-8,176m
	18,096m	12,360m
Investments (gains) losses	-7,734m	-13,741m
	13,318m	14,690m
Net income	-	-
	21,468m	16,472m
	-3,372m	-4,112m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.